Medical Oncologist
CION Cancer Clinics
Systemic treatment for liver cancer with Child-Pugh B liver function | CION Cancer Clinics
Some people with Child-Pugh B liver function can still have immunotherapy or tablets for liver cancer, but the evidence is thinner and the margin for safety is smaller. The decision depends on where you sit within class B, what pushed the score there and how active you are. This page explains what the team weighs, which options are discussed, and when cancer treatment is unlikely to help. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Can you have systemic treatment with Child-Pugh B liver function?
- What decides whether treatment is safe with Child-Pugh B?
- What happens before treatment is started?
- Which options are discussed with Child-Pugh B?
- When is cancer treatment unlikely to help?
- What this page cannot tell you
- Common questions about treatment with Child-Pugh B
The short answer
Can you have systemic treatment with Child-Pugh B liver function?
Sometimes, yes, but with more caution and less certainty than for someone whose liver is working well. This page is for people with primary liver cancer (hepatocellular carcinoma, or HCC) and cirrhosis whose liver has been scored as Child-Pugh B, where immunotherapy or tablets are being considered.
What Child-Pugh B means
Child-Pugh is a score built from blood tests and a few questions about how the liver is coping: bilirubin (the yellow pigment that causes jaundice), albumin (a protein the liver makes), INR (how quickly blood clots), fluid in the belly, and confusion. Class A means the liver is coping well. Class B means it is moderately damaged. Class C means it is failing. The Child-Pugh explained page walks through the score itself.
Why it changes the decision
Most of the large trials that set today's standard treatments only enrolled people with Child-Pugh A. That means doctors have much less direct evidence for Child-Pugh B. The drugs can still help some people, but the liver has less reserve to absorb side effects, and the cirrhosis itself may shape the future as much as the cancer does.
If your cancer started somewhere else and spread to the liver, Child-Pugh scoring is rarely used. See primary versus secondary liver cancer.What the team weighs
What decides whether treatment is safe with Child-Pugh B?
Child-Pugh B is a wide band. Two people with the same letter can be in very different places.
Where you sit within B
The score runs across several points inside class B. People at the lower end, close to class A, are often treated much like class A. People at the upper end, close to class C, rarely gain from cancer drugs.
What pushed the score into B
A slightly low albumin is a different story from fluid that keeps coming back or episodes of confusion. Ascites (fluid in the belly) and hepatic encephalopathy (confusion from the liver) weigh heavily.
The team will ask
- Has there been fluid in the belly, and how hard was it to control?
- Any confusion, drowsiness or a hospital stay for it?
- Any bleeding from varices, the swollen veins in the food pipe?
How active you are
Someone who still walks, eats and looks after themselves copes with treatment far better than someone who spends most of the day lying down.
Whether the liver can recover
Controlling hepatitis B, curing hepatitis C with tablets, stopping alcohol or treating fluid can sometimes move a score back towards A. That can open up options that were not safe before.
Not sure whether this applies to you?
Ask an oncologistHow the decision is made
What happens before treatment is started?
Recheck the liver score
A score taken during an infection, a bleed or a fresh drink of alcohol can look worse than the liver really is. Repeat blood tests after the acute problem settles give a truer picture.
Treat the liver disease first
A hepatologist or physician starts antivirals for hepatitis B, treats fluid and confusion, and checks nutrition. Many families cut protein, but people with cirrhosis usually need enough protein, not less.
An endoscopy if bevacizumab is considered
Bevacizumab raises bleeding risk, so swollen veins are looked for and banded first. The endoscopy page explains why. CION coordinates this through partner hospitals.
The tumour board discussion
The oncologist, hepatologist and radiologist weigh the cancer against the cirrhosis together, and decide whether treatment is likely to help more than it harms.
A careful start and close review
If treatment begins, blood tests are checked often. The team stops or changes course quickly if the liver worsens.
Side by side
Which options are discussed with Child-Pugh B?
Option
How it is viewed with Child-Pugh B
Atezolizumab plus bevacizumab
Used by some teams at the milder end of B, with limited evidence and an endoscopy first
Immunotherapy on its own
Sometimes chosen because it avoids the bleeding risk of bevacizumab
Sorafenib or lenvatinib
Used with caution; side effects such as diarrhoea and tiredness hit harder in a weak liver
TACE or radiation to the liver
Considered only in selected people; see the separate pages on each
Supportive care focused on the liver
Often the right choice at the upper end of B, and active care in its own right
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Being clear
When is cancer treatment unlikely to help?
Systemic treatment usually does not suit people at the upper end of Child-Pugh B with fluid that keeps returning, repeated confusion or a recent variceal bleed. It also usually does not suit those who are mostly confined to bed, or whose liver is getting worse month by month. For them, the cirrhosis is often the bigger threat, and cancer drugs can speed up liver failure.
Why saying no can be the kind answer
Families sometimes hear "no further cancer treatment" as "nothing can be done". That is not what it means. Treating fluid, itching, pain, confusion and appetite, and protecting the time a person has, is real treatment. The palliative care page explains how this works alongside or instead of cancer drugs.
Who this page does not apply to
People with Child-Pugh A have more options and stronger evidence behind them. People with Child-Pugh C are not usually offered cancer drugs at all. People whose liver may be suitable for a transplant need a different conversation with a transplant centre.
Being straight with you
What this page cannot tell you
It cannot tell you whether a particular drug is safe for your liver. That depends on your exact score, what drove it, your other illnesses and how you are managing day to day. Only a team that has your blood results and scans can weigh that.
The evidence here is thin
Most information on Child-Pugh B comes from smaller studies and real-world records, not from large trials. Experienced specialists sometimes reach different answers for the same person. That reflects genuine uncertainty, and it is reasonable to ask for a second view.
What CION does
CION's medical oncologists review your case at the tumour board, give immunotherapy and targeted therapy, and provide supportive care. Hepatology care, endoscopy and liver procedures are coordinated through partner hospitals and hepatologists. The reviewing team will tell you who is doing what.
Bring your latest blood reports, scans and a list of every medicine and herbal product you take.Questions we are asked
Common questions about treatment with Child-Pugh B
Can Child-Pugh B improve to Child-Pugh A?
Sometimes. Controlling hepatitis B, clearing hepatitis C, stopping alcohol, treating fluid and improving nutrition can all lift the score. It does not happen for everyone, and it takes time. If it does improve, the team may revisit options that were set aside.
Is immunotherapy safer than tablets for a weak liver?
Not simply. Immunotherapy can inflame the liver, and tablets cause tiredness and diarrhoea that a weak liver tolerates poorly. Each carries different risks. The immunotherapy with cirrhosis page explains the immune side of this in more detail.
Why was my father refused treatment when his scan looks the same as before?
The decision often depends more on the liver than on the tumour. If his blood tests, fluid or alertness have worsened, cancer drugs could tip the liver into failure. Ask the team to explain which of his results drove the decision, and whether a recheck later could change it.
Should we reduce protein in his diet?
Usually not. Many families cut dal, eggs and milk because they fear protein harms the liver. Most people with cirrhosis need enough protein to keep their muscles and strength. A dietitian or hepatologist will give advice if confusion is a problem.
Are the drugs available in India?
Atezolizumab, bevacizumab, sorafenib and lenvatinib are available in India, and generic versions exist for some. Availability of other combinations varies. Your oncologist can tell you what is accessible now and whether any patient assistance programme applies.
Does Child-Pugh B mean the cancer is advanced?
No. Child-Pugh describes the liver, not the cancer. A small cancer can sit in a weak liver, and a large one in a strong liver. Staging systems such as BCLC put the two together to guide treatment.
What warning signs should we watch for during treatment?
Go to hospital today for vomiting blood, black stools, new confusion or drowsiness, or fever with a swollen belly. Call the team the same day about yellowing eyes, a fast-growing belly or diarrhoea that will not settle.
Can we get a second opinion on this decision?
Yes, and with Child-Pugh B it is often worthwhile because the evidence is limited. Take the blood reports, scan discs, endoscopy report and treatment summary. A CION medical oncologist can review the case with the tumour board.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- EASL — EASL Clinical Practice Guidelines: management of hepatocellular carcinoma
- MDCalc — Child-Pugh Score for Cirrhosis Mortality Calculator
- American Cancer Society — Treatment of Liver Cancer, by Stage
- American Cancer Society — Immunotherapy for Liver Cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Why Child-Pugh decides what treatment you can haveHow the liver score shapes every optionWho cannot have atezolizumab plus bevacizumabThe first-line combination and its limitsCompensated vs decompensated cirrhosisWhat fluid, confusion and bleeding mean for the liverSystemic treatment with hepatitis B still activeGetting the virus under control before treatment
Talk to us
Told the liver is too weak for treatment?
A CION medical oncologist can review the blood reports and scans with the tumour board and explain what is safe for this liver. One helpline serves every CION centre.